.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Julphar
Argus Health
Farmers Insurance
McKesson
UBS
Deloitte
Baxter
Harvard Business School
US Department of Justice

Generated: February 21, 2018

Austria Drug Patents

These international patent data are derived from patent families, based on US drug-patent linkages.
They should not be regarded as comprehensive records of ex-US drug-patent associations.

Document Number Estimated Expiration Equivalent US Patent US Expiry Date Generic Name US Applicant US Tradename
514002➤ Sign Up8492386Sep 4, 2032dasabuvir sodium; ombitasvir; paritaprevir; ritonavirAbbvie IncVIEKIRA XR
514002➤ Sign Up8492386Sep 4, 2032dasabuvir sodium ; ombitasvir; paritaprevir; ritonavirAbbvie IncVIEKIRA PAK (COPACKAGED)
514003➤ Sign Up8680106Sep 4, 2032dasabuvir sodium; ombitasvir; paritaprevir; ritonavirAbbvie IncVIEKIRA XR
514003➤ Sign Up8680106Sep 4, 2032dasabuvir sodium ; ombitasvir; paritaprevir; ritonavirAbbvie IncVIEKIRA PAK (COPACKAGED)
514002➤ Sign Up8685984Sep 4, 2032dasabuvir sodium; ombitasvir; paritaprevir; ritonavirAbbvie IncVIEKIRA XR
514003➤ Sign Up8466159Sep 4, 2032dasabuvir sodium; ombitasvir; paritaprevir; ritonavirAbbvie IncVIEKIRA XR
514002➤ Sign Up8685984Sep 4, 2032dasabuvir sodium ; ombitasvir; paritaprevir; ritonavirAbbvie IncVIEKIRA PAK (COPACKAGED)
514003➤ Sign Up8466159Sep 4, 2032dasabuvir sodium ; ombitasvir; paritaprevir; ritonavirAbbvie IncVIEKIRA PAK (COPACKAGED)
526024➤ Sign Up7816383Jan 8, 2030pirfenidoneGenentech IncESBRIET
523197➤ Sign Up8754109Jan 8, 2030pirfenidoneGenentech IncESBRIET
This preview shows a limited number of results
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Medtronic
Queensland Health
AstraZeneca
Federal Trade Commission
Moodys
Chubb
McKesson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot